Constipation in chronic hemodialysis patients
Conditions
Interventions
Mini-jelly containing polydextrose (10g/day)
Placebo (mini-jelly without polydextrose)
Sponsors
Heisei Hidaka clinic
Tokyo University of Agriculture
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Chronic hemodialysis patients with constipation
Exclusion criteria
Exclusion criteria: 1) Patients with organic bowel diseases (e.g.; inflammatory bowel disease or colon cancer) 2) Patients who start or change the usage of P, K, cholesterol-binding agents during the study 3) Patients already treated with dietary fibers or Lactobacillus preparations as a supplement 4) Patients hospitalized during the study 5) When an appearance of side effects which seem to be related with dietary fiber mini-jelly or the placebo jelly during the study 6) Patients uncontrolled by hemodialysis during the study 7) Patients showing remarkably poor bowel movements during the study 8) Patients determined by doctors that the study continuation is inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of bowel movements | — |
Secondary
| Measure | Time frame |
|---|---|
| #Blood biochemistry (BUN,Cr,Ca,P,Alb, hepatic function) #Dose and usage frequency of medicines for constipation #Stool form and abdominal symptom #Side effects of a dietary fiber | — |
Countries
Japan
Contacts
Public ContactMikiko Shimada
Hidaka rehabilitation hospital Department of Nutrition
Outcome results
None listed